Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
Lancet Reg Health Eur
.
2022 Nov 11:23:100537.
doi: 10.1016/j.lanepe.2022.100537.
eCollection 2022 Dec.
Authors
Freja Cordelia Møller Kirsebom
1
,
Nick Andrews
1
2
,
Julia Stowe
1
,
Natalie Groves
1
,
Meera Chand
1
3
,
Mary Ramsay
1
2
,
Jamie Lopez Bernal
1
2
4
Affiliations
1
UK Health Security Agency, London, United Kingdom.
2
NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom.
3
Guys and St Thomas's Hospital NHS Trust, London, United Kingdom.
4
NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, London, United Kingdom.
PMID:
36381141
PMCID:
PMC9649815
DOI:
10.1016/j.lanepe.2022.100537
No abstract available